{"id":3142,"date":"2015-02-19T07:30:00","date_gmt":"2015-02-19T07:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xps-godkand-i-australien\/"},"modified":"2015-02-19T07:30:00","modified_gmt":"2015-02-19T07:30:00","slug":"xps-godkand-i-australien","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-godkand-i-australien\/","title":{"rendered":"XPS\u2122 godk\u00e4nd i Australien"},"content":{"rendered":"
XVIVO Perfusion har erh\u00e5llit TGA godk\u00e4nnande f\u00f6r XPS\u2122 (Xvivo Perfusion System) i Australien. Detta m\u00f6jligg\u00f6r f\u00f6rs\u00e4ljning av XPS\u2122 i Australien.<\/strong><\/div>\n<\/p>\n

XPS\u2122 \u00e4r med sin integrerade Hamilton C2 ventilator och MAQUET CardioHelp centrifugalpump marknadens mest flexibla och kompletta plattform f\u00f6r EVLP (Ex Vivo Lung Perfusion) och ger transplantationsteamet full kontroll \u00f6ver hela processen. XPS\u2122-designen inneb\u00e4r att r\u00f6ntgen och automatisk m\u00e4tning av syre och pH kan g\u00f6ras under p\u00e5g\u00e5ende EVLP utv\u00e4rdering. XPS\u2122 har ett anv\u00e4ndarv\u00e4nligt grafiskt gr\u00e4nssnitt med touchscreen-funktionalitet och dataregistrering av lungans v\u00e4rden under hela EVLP-proceduren, vilket ger underlag till analys och utv\u00e4rdering inf\u00f6r slutligt kliniskt beslut om anv\u00e4ndande av lungan. <\/span><\/p>\n<\/p>\n

XVIVO Perfusions XPS\u2122 och STEEN Solution\u2122 \u00e4r de enda godk\u00e4nda produkterna i USA f\u00f6r evaluering av marginella lungor inf\u00f6r lungtransplantation. XPS\u2122 och STEEN Solution\u2122 \u00e4r ocks\u00e5 CE \u2013 m\u00e4rkt f\u00f6r Europa. XPS\u2122 anv\u00e4nds med goda kliniska resultat p\u00e5 ledande kliniker i USA och f\u00f6rs\u00e4ljningen b\u00f6rjar ta fart i Europa. <\/span><\/p>\n<\/p>\n

Det g\u00f6rs knappt tv\u00e5hundra lungtransplantationer per \u00e5r i Australien. XPS\u2122 med STEEN Solution\u2122 m\u00f6jligg\u00f6r att fler lungor kan anv\u00e4ndas till transplantation, vilket g\u00f6r att fler sv\u00e5rt lungsjuka patienter erh\u00e5ller h\u00f6gre livskvalitet och ett l\u00e4ngre liv.<\/span><\/p>\n<\/p>\n

\u201dDet \u00e4r mycket gl\u00e4djande att XPS\u2122 nu \u00e4r tillg\u00e4nglig f\u00f6r kliniskt lungtransplantation i Australien. I och med godk\u00e4nnandet i Australien \u00e4r XPS\u2122 nu godk\u00e4nd p\u00e5 alla stora marknader i v\u00e4rlden", s\u00e4ger VD Magnus Nilsson, XVIVO Perfusion.<\/span><\/p>\n<\/p>\n

G\u00f6teborg 19 februari 2015
XVIVO Perfusion AB (publ)<\/span><\/p>\n

\n

F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/p>\n

Christoffer Rosenblad, CFO, tel: 031-788 21 59, e-post: christoffer.rosenblad@xvivoperfusion.com<\/a>
F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/a><\/span><\/p>\n

Informationen l\u00e4mnades f\u00f6r publicering den\u00a019 februari 2015 kl. 08:30.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

XVIVO Perfusion har erh\u00e5llit TGA godk\u00e4nnande f\u00f6r XPS\u2122 (Xvivo Perfusion System) i Australien. Detta m\u00f6jligg\u00f6r f\u00f6rs\u00e4ljning av XPS\u2122 i Australien….<\/p>\n","protected":false},"template":"","class_list":["post-3142","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-listing"],"acf":[],"yoast_head":"\nXPS\u2122 godk\u00e4nd i Australien - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-godkand-i-australien\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XPS\u2122 godk\u00e4nd i Australien - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion har erh\u00e5llit TGA godk\u00e4nnande f\u00f6r XPS\u2122 (Xvivo Perfusion System) i Australien. Detta m\u00f6jligg\u00f6r f\u00f6rs\u00e4ljning av XPS\u2122 i Australien....\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-godkand-i-australien\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-godkand-i-australien\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-godkand-i-australien\\\/\",\"name\":\"XPS\u2122 godk\u00e4nd i Australien - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2015-02-19T07:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-godkand-i-australien\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-godkand-i-australien\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-godkand-i-australien\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XPS\u2122 godk\u00e4nd i Australien\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XPS\u2122 godk\u00e4nd i Australien - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-godkand-i-australien\/","og_locale":"en_US","og_type":"article","og_title":"XPS\u2122 godk\u00e4nd i Australien - XVIVO","og_description":"XVIVO Perfusion har erh\u00e5llit TGA godk\u00e4nnande f\u00f6r XPS\u2122 (Xvivo Perfusion System) i Australien. Detta m\u00f6jligg\u00f6r f\u00f6rs\u00e4ljning av XPS\u2122 i Australien....","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-godkand-i-australien\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-godkand-i-australien\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-godkand-i-australien\/","name":"XPS\u2122 godk\u00e4nd i Australien - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2015-02-19T07:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-godkand-i-australien\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-godkand-i-australien\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-godkand-i-australien\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XPS\u2122 godk\u00e4nd i Australien"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3142","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3142"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}